HOME >> MEDICINE >> NEWS
Queensland to be hub of Australasian kidney network

The growing problem of kidney disease will be tackled head on with the formation of a new Queensland-based research network.

To be co-ordinated through The University of Queensland's Queensland Clinical Trials Centre at the Princess Alexandra Hospital, the $1.29 million Australasian Kidney Trials Network (AKTN) will aim to improve the health and quality of life of people suffering from kidney disease.

Associate Professor Carmel Hawley, Chair of the Brisbane-based Operations Secretariat of the Network, said the AKTN would draw together leading researchers in kidney disease from around Australia and New Zealand.

"Kidney disease is one biggest health issues facing Australia at the moment along with heart disease and diabetes," Dr Hawley said.

"It affect one in seven Australian adults and there are 1.7 million people with moderate to severe chronic kidney disease.

"This Network will be focused on new and innovative clinical research to provide better treatments and outcomes for patients.

"We already have 10 trials submitted to the network researching varying treatments for chronic kidney diseases such as dialysis and transplants."

Dr Hawley said kidney disease affected one in seven Australian adults, with 1.7 million people with moderate to severe chronic kidney disease.

Other UQ researchers involved in the Network include Elaine Beller from the School of Population Health and Professors David Johnson and Wendy Hoy from the School of Medicine.

Dr Hawley said this focus on treatment and prevention trials was unique in Australia and would be a new approach to the varying renal diseases.

"The Network will be at the forefront of knowledge creation and address complex economic, technological and social needs relating to the patient care and the translation of research into clinical practice," she said.

The AKTN is the recipient of an National Health and Medical Research Council
'"/>

Contact: Associate Professor Carmel Hawley
61-732-405-080
Research Australia
14-Jul-2005


Page: 1 2

Related medicine news :

1. University of Queensland and Harvard Medical International to nourish the health workforce
2. 1 of 2 pediatric kidney disease research centers in world established
3. Indiana University Imaging Center receives $6M grant for kidney research
4. Obesity linked to hyperparathyroidism in chronic kidney disease
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
7. Quality versus quantity -- transforming kidney transplant policy
8. ACE inhibitors help preserve kidney function in IgA nephropathy
9. Treatment of kidney condition requires an individualized approach
10. Study evaluates why blacks do not successfully donate kidneys
11. Cause of gender differences in blood pressure, kidney damage under study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... development at Tocagen, will present at Phacilitate Cell & Gene ... Miami . Details of the podium ... ... what to do when and why Date and Time: Wednesday, Jan. ...
(Date:1/17/2017)... Research and Markets has announced the addition ... Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, ... report to their offering. ... The global active pharmaceutical ingredients market is expected ... in 2016, growing at a CAGR of 6.3% from 2016 to ...
(Date:1/17/2017)... -- Immune Pharmaceuticals (NASDAQ: IMNP ) ("Immune"), ... will hold a Satellite Symposium on February 20th, 2017 at ... Munich, Germany . The ... for the maintenance of remission in AML with Ceplene" ... 2017 from 12:45 – 13:45 CET in Lecture Hall ...
Breaking Medicine Technology:
Cached News: